Important: Therapy notes
- The treatment of children with Decapeptyl SR 11·25mg or 22·5mg should be under the overall supervision of a paediatric endocrinologist or of a paediatrician or an endocrinologist with expertise in the treatment of central precocious puberty.
- The vial includes an overage to allow administration of the dose.
Important: Formulation and dosage details
Formulation:
Powder for suspension for injection vial (Decapeptyl® SR) 3mg, 11·25mg, 22·5mg (s)
Dosage:
Endometriosis and reduction in size of uterine fibroids, by intramuscular injection, 3mg every 4 weeks starting during first 5 days of menstrual cycle; for uterine fibroids continue treatment for at least 3 months; maximum duration of treatment 6 months (not to be repeated);
Endometriosis, by intramuscular injection, 11·25mg every 3 months for maximum 6 months (not to be repeated) starting during first 5 days of menstrual cycle.